Q4 2023 Holdings
Filed 2024-02-14 | 104 holdings | $4.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Nuvation BIO Inc(NUVB/WS) | *W EXP 07/07/202 | 67080N119 | $8.0K | 134,028 | 0.0% |
| Acelrx Pharmaceuticals Inc(TLPH) | COM NEW | 00444T209 | $232.6K | 316,460 | 0.0% |
| Nevro Corp | NOTE 2.750% 4/0 | 64157FAC7 | $481.8K | $500,000 | 0.0% |
| Xilio Therapeutics Inc(XLO) | COM | 98422T100 | $792.4K | 1,440,759 | 0.0% |
| Vincerx Pharma Inc | COM NEW | 92731L106 | $1.1M | 891,719 | 0.0% |
| Reneo Pharmaceuticals Inc(RPHM) | COM | 75974E103 | $1.2M | 751,730 | 0.0% |
| Vigil Neuroscience Inc(VIGL) | COM | 92673K108 | $1.6M | 471,958 | 0.0% |
| Neurocrine Biosciences Inc | NOTE 2.250% 5/1 | 64125CAD1 | $1.8M | $1,000,000 | 0.0% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $1.9M | 2,425,468 | 0.0% |
| Compugen LTD(CGEN) | ORD | M25722105 | $2.6M | 1,289,990 | 0.1% |
| Novavax Inc(NVAX) | COM NEW | 670002401 | $2.6M | 537,625 | 0.1% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $2.6M | 181,147 | 0.1% |
| Travere Therapeutics Inc | NOTE 2.500% 9/1 | 761299AB2 | $2.8M | $3,250,000 | 0.1% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $3.0M | 3,266,960 | 0.1% |
| Applied Therapeutics Inc(APLT) | COM | 03828A101 | $3.0M | 895,195 | 0.1% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $3.0M | 111,430 | 0.1% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $3.1M | 2,998,495 | 0.1% |
| Leap Therapeutics Inc(CYPH) | COM NEW | 52187K200 | $3.5M | 832,937 | 0.1% |
| Gossamer BIO Inc | NOTE 5.000% 6/0 | 38341PAA0 | $3.5M | $9,573,000 | 0.1% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $3.7M | 412,570 | 0.1% |
| Sagimet Biosciences Inc(SGMT) | COM SER A | 786700104 | $4.0M | 738,355 | 0.1% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $4.5M | 677,005 | 0.1% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $4.9M | 727,673 | 0.1% |
| Oscar Health Inc(OSCR) | CL A | 687793109 | $6.7M | 735,000 | 0.2% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $7.0M | 384,996 | 0.2% |
| Mersana Therapeutics Inc | COM | 59045L106 | $7.1M | 3,046,782 | 0.2% |
| Edap TMS S A(EDA) | SPONSORED ADR | 268311107 | $7.3M | 1,386,425 | 0.2% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $7.4M | 673,966 | 0.2% |
| Spruce Biosciences Inc | COM | 85209E109 | $7.6M | 2,609,125 | 0.2% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $7.9M | 535,012 | 0.2% |
| Pulmonx Corp(LUNG) | COM | 745848101 | $8.3M | 652,400 | 0.2% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $8.6M | 5,513,788 | 0.2% |
| Acumen Pharmaceuticals Inc(ABOS) | COM | 00509G209 | $8.8M | 2,300,059 | 0.2% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $10.0M | 1,167,492 | 0.2% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $11.3M | 1,178,796 | 0.3% |
| Inhibrx Inc(INBXUSD)Call | COM | 45720L107 | $11.5M | 301,400 | 0.3% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $11.7M | 286,676 | 0.3% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $12.9M | 103,969 | 0.3% |
| Icosavax Inc | COM | 45114M109 | $13.7M | 868,409 | 0.3% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $14.4M | 148,832 | 0.4% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $15.1M | 1,063,806 | 0.4% |
| Inozyme Pharma Inc | COM | 45790W108 | $15.7M | 3,681,174 | 0.4% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $17.3M | 562,000 | 0.4% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $18.4M | 7,983,851 | 0.5% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $19.6M | 3,270,381 | 0.5% |
| Immatics N.v(IMTX) | SHS | N44445109 | $19.7M | 1,875,466 | 0.5% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $20.1M | 99,000 | 0.5% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $20.8M | 725,152 | 0.5% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $21.0M | 363,468 | 0.5% |
| Amgen Inc(AMGN) | COM | 031162100 | $21.5M | 74,500 | 0.5% |